HOME >> BIOLOGY >> NEWS
Only 21 states offer newborn screening tests recommended by March of Dimes

WHITE PLAINS, N.Y., JUNE 30, 2004 Seventy percent of babies born in the U.S. still fail to get the minimal number of newborn tests recommended by the March of Dimes, according to the non-profit's 2004 state-by-state report card on newborn screening.

The March of Dimes is the first national health organization to recommend that every baby born in the U.S. receive, at a minimum, screening for the same core group of nine metabolic disorders as well as hearing deficiency. The March of Dimes encourages states to add more screening tests as resources and capabilities allow.

Few parents realize that the extent of this testing depends entirely on the state in which their baby is born. These tests can sometimes mean the difference between a healthy start in life and disability, or even death, the March of Dimes says.

"The number of screened disorders continues to vary greatly by state. Here we have a simple and inexpensive solution to a potentially devastating problem, and it's time for all states to make newborn screening a top priority," says Dr. Jennifer L. Howse, president of the March of Dimes and a member of the U.S. Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

"Our chapter staff and volunteers have been working closely with governors, state legislators, and health departments to increase access to these important tests," Dr. Howse says. "I'm encouraged to report today that since this time last year, the number of states that test for the nine core metabolic disorders has risen from nine to 21."

Currently, 21 states screen for the March of Dimes-recommended list of metabolic disorders: Alaska, Connecticut, Hawaii, Idaho, Illinois, Indiana, Iowa, Maine, Maryland, Massachusetts, Mississippi, Nevada, New York, North Dakota, Oregon, Rhode Island, Tennessee, Vermont, Virginia, Washington, and Wisconsin. In 2002, these states accoun
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
30-Jun-2004


Page: 1 2 3

Related biology news :

1. Alternative states in the ocean
2. Mathematical models reveal molten and glassy states of RNA
3. Not all enlarged prostates are the same, say University of Pittsburgh researchers
4. Canine leishmaniasis cases are confirmed in 21 states
5. Genetic extremism overstates risks
6. Lake research offers clues to managing crayfish invasions
7. Comparing primate genomes offers insight into human evolution
8. UW study: Migrating birds offer insight into sleep
9. Study of proteins offers insights into organization of biological networks
10. Susceptibility of mice to mousepox offers promise of smallpox protection
11. Discovery in parasite movement may offer insights into malaria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone ... companies, has announced the placement of Julianne Averill , CPA, as Chief ... all financial operations and implementing key business strategies to accelerate Alveo’s growth as ...
(Date:8/12/2020)... , ... August 11, 2020 ... ... biopharmaceutical cold chain validation engineering firm, is making available for free its ... need to incorporate concurrent transport simulation testing into today’s biologics licensing application ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management ... reasons it did not take off as quickly as people initially expected, and where ... towards capturing data electronically for clinical trials and then repurposing it for downstream analysis, ...
Breaking Biology Technology:
Cached News: